GlaxoSmithKline | GJELD



Debt Endring Dato
AbbVie USD 67.14B 3.94B 2024-12
Alcon AG USD 4.64B 470M 2024-12
Almirall EUR 408.66M 56.36M 2024-06
Amgen USD 60.1B 299M 2024-12
AstraZeneca USD 31.65B 1.35B 2025-03
Bayer EUR 40.7B 465M 2024-12
Biogen USD 6.3B 1.9M 2024-12
Bristol-Myers Squibb USD 49.71B 62M 2025-03
Eli Lilly USD 38.52B 4.87B 2025-03
Fresenius EUR 13.28B 40M 2024-12
Fresenius Medical Care EUR 10.98B 225M 2024-12
Galapagos EUR 10.86M 864K 2025-03
Genmab DKK 1.03B 42M 2024-12
Gilead Sciences USD 26.71B 3.46B 2024-12
GlaxoSmithKline GBP 18.43B 1.45B 2025-03
Glaxosmithkline GBP 16.99B 927M 2024-12
GRIFOLS EUR 9.23B 626.05M 2024-12
Hikma Pharmaceutical USD 1.28B 85M 2024-06
Lonza CHF 4.71B 915M 2024-12
Merck EUR 10.27B 1.11B 2024-12
Merck USD 37.11B 1.02B 2024-12
Novartis USD 31.26B 828M 2024-12
Novo Nordisk 56.97B 88M 2024-09
Orion EUR 321.2M 6M 2025-03
Pfizer USD 64.35B 3.35B 2024-12
Philips EUR 7.64B 394M 2024-12
Recordati EUR 1.56B 120M 2024-09
Regeneron Pharmaceuticals USD 2.7B 400K 2025-03
Roche Holding CHF 34.44B 5.23B 2024-06
Sanofi 21.05B 3.14B 2025-03
Smith & Nephew USD 3.32B 334M 2024-12
UCB EUR 3.03B 13M 2024-12



GlaxoSmithKline GJELD - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.